Update on the Role of Bone Biopsy in the Management of Patients with CKD-MBD

Overview

Journal J Nephrol

Publisher Springer

Specialty Nephrology

Date 2017 Aug 24

PMID 28831679

Citations 24

Authors

P Evenepoel

G J S Behets

M R Laurent

P C DHaese

Affiliations

Soon will be listed here.

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of fractures. The fracture risk steadily increases along with the progression of renal disease to become several-fold higher in end-stage renal disease (ESRD) patients as compared to age and sex-matched controls. Renal osteodystrophy (ROD) is a heterogeneous group of metabolic bone diseases complicating progressive chronic kidney disease. Bone biomarkers and bone imaging techniques may help to assess bone health and predict fractures in CKD, but do have important inherent limitations. The gold standard for the diagnosis and specific classification of renal osteodystrophy (ROD) remains the (quantitative) histomorphometric analysis of the bone biopsy. By informing on bone turnover and mineralization, a bone biopsy may help guide prevention and treatment of ROD and its consequences. This review aims to present an update on epidemiological and procedural aspects, clinical indications, and histomorphometric analysis of bone biopsies and to define the role of bone biopsy in current CKD-MBD care.

Citing Articles

Decoding pathology: the role of computational pathology in research and diagnostics.

Holscher D, Bulow R Pflugers Arch. 2024; .

PMID: 39095655 DOI: 10.1007/s00424-024-03002-2.

Ten tips on how to assess bone health in patients with chronic kidney disease.

Jorgensen H, Lloret M, Lalayiannis A, Shroff R, Evenepoel P Clin Kidney J. 2024; 17(5):sfae093.

PMID: 38817914 PMC: 11137676. DOI: 10.1093/ckj/sfae093.

Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.

Kim K, Ha J, Kim S, Kim J, Lee S, Choi H Endocrinol Metab (Seoul). 2024; 39(2):267-282.

PMID: 38693817 PMC: 11066446. DOI: 10.3803/EnM.2024.1939.

Assessment of regional and total skeletal metabolism using F-NaF PET/CT in patients with chronic kidney disease.

Usmani S, Ahmed N, Gnanasegaran G, Marafi F, Bani-Mustafa A, Van den Wyngaert T Ann Nucl Med. 2024; 38(7):563-573.

PMID: 38676905 DOI: 10.1007/s12149-024-01929-1.

Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease.

Elkhouli E, Nagy E, Santos C, Barreto F, Chaer J, Jorgetti V Osteoporos Int. 2023; 34(12):2003-2012.

PMID: 37658999 DOI: 10.1007/s00198-023-06886-5.

References

Miller P . The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol. 2008; 3 Suppl 3:S140-50. PMC: 3152286. DOI: 10.2215/CJN.02430508. View

Sutton-Smith P, Beard H, Fazzalari N . Quantitative backscattered electron imaging of bone in proximal femur fragility fracture and medical illness. J Microsc. 2008; 229(Pt 1):60-6. DOI: 10.1111/j.1365-2818.2007.01867.x. View

Lindergard B, Johnell O, NILSSON B, WIKLUND P . Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron. 1985; 39(2):122-9. DOI: 10.1159/000183355. View

Hamdy N, Kanis J, Beneton M, Brown C, Juttmann J, Jordans J . Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995; 310(6976):358-63. PMC: 2548761. DOI: 10.1136/bmj.310.6976.358. View

Tentori F, McCullough K, Kilpatrick R, Bradbury B, Robinson B, Kerr P . High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2013; 85(1):166-73. PMC: 3910091. DOI: 10.1038/ki.2013.279. View

Hernandez J, Wesseling K, Pereira R, Gales B, Harrison R, Salusky I . Technical approach to iliac crest biopsy. Clin J Am Soc Nephrol. 2008; 3 Suppl 3:S164-9. PMC: 3152282. DOI: 10.2215/CJN.00460107. View

Dierolf M, Menzel A, Thibault P, Schneider P, Kewish C, Wepf R . Ptychographic X-ray computed tomography at the nanoscale. Nature. 2010; 467(7314):436-9. DOI: 10.1038/nature09419. View

Campbell G, Sophocleous A . Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies. Bonekey Rep. 2014; 3:564. PMC: 4140449. DOI: 10.1038/bonekey.2014.59. View

Casanova M, Balmelli A, Carnelli D, Courty D, Schneider P, Muller R . Nanoindentation analysis of the micromechanical anisotropy in mouse cortical bone. R Soc Open Sci. 2017; 4(2):160971. PMC: 5367284. DOI: 10.1098/rsos.160971. View

10.

Spasovski G, Bervoets A, Behets G, Ivanovski N, Sikole A, Dams G . Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant. 2003; 18(6):1159-66. DOI: 10.1093/ndt/gfg116. View

11.

Ok E, Asci G, Bayraktaroglu S, Toz H, Ozkahya M, Yilmaz M . Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol. 2015; 27(8):2475-86. PMC: 4978036. DOI: 10.1681/ASN.2015030268. View

12.

Paschalis E, Mendelsohn R, Boskey A . Infrared assessment of bone quality: a review. Clin Orthop Relat Res. 2011; 469(8):2170-8. PMC: 3126953. DOI: 10.1007/s11999-010-1751-4. View

13.

de Oliveira R, Barreto F, Mendes M, Dos Reis L, Castro J, Britto Z . Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int. 2014; 87(5):1039-45. DOI: 10.1038/ki.2014.372. View

14.

Ketteler M, Block G, Evenepoel P, Fukagawa M, Herzog C, McCann L . Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017; 92(1):26-36. DOI: 10.1016/j.kint.2017.04.006. View

15.

Wilson L, Rebholz C, Jirru E, Liu M, Zhang A, Gayleard J . Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med. 2017; 166(9):649-658. DOI: 10.7326/M16-2752. View

16.

Amling M, Herden S, Posl M, Hahn M, Ritzel H, Delling G . Heterogeneity of the skeleton: comparison of the trabecular microarchitecture of the spine, the iliac crest, the femur, and the calcaneus. J Bone Miner Res. 1996; 11(1):36-45. DOI: 10.1002/jbmr.5650110107. View

17.

Jadoul M, Albert J, Akiba T, Akizawa T, Arab L, Bragg-Gresham J . Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006; 70(7):1358-66. DOI: 10.1038/sj.ki.5001754. View

18.

Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

19.

Malluche H, Monier-Faugere M . The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol. 1994; 4(9):1631-42. DOI: 10.1681/ASN.V491631. View

20.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K . Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 69(11):1945-53. DOI: 10.1038/sj.ki.5000414. View